Physician profile
Barbara A Soltes
NPI 1164591301
$25,257.19
in general payments reported to CMS, 2019-2025
10 companies · $17.62 in 2025
The $17.62 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $6,066 · 2021: $5,913 · 2022: $191 · 2023: $98.61 · 2025: $17.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $24,959.45 | 2019-2022 | |
| Astellas Pharma US INC | $142.61 | 2022-2025 | Veozah |
| Sumitomo Pharma America, INC. | $98.61 | 2023 | Myfembree |
| Myovant Sciences INC. | $26.47 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.97 | 2021 | |
| Therapeuticsmd, INC. | $12.08 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Soltes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.